BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35918966)

  • 1. The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment.
    Goh WN; Mustapha M; Zakaria SZS; Bastion MC
    Indian J Ophthalmol; 2022 Aug; 70(8):3026-3032. PubMed ID: 35918966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.
    Nguyen JH; Nguyen-Cuu J; Yu F; Yee KM; Mamou J; Silverman RH; Ketterling J; Sebag J
    Ophthalmology; 2019 Nov; 126(11):1517-1526. PubMed ID: 31471088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
    Shah CP; Heier JS
    JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.
    Kokavec J; Wu Z; Sherwin JC; Ang AJ; Ang GS
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011676. PubMed ID: 28570745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of YAG laser vitreolysis in patients with symptomatic vitreous floaters.
    Souza CE; Lima LH; Nascimento H; Zett C; Belfort R
    Int J Retina Vitreous; 2020; 6():1. PubMed ID: 31988795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial.
    Hangshuai Z; Yanhua J; Yao Z; Guangjin Z; Hongyan W; Fanlian C
    Trials; 2024 Jan; 25(1):48. PubMed ID: 38218919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.
    Delaney YM; Oyinloye A; Benjamin L
    Eye (Lond); 2002 Jan; 16(1):21-6. PubMed ID: 11913884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous floaters: A randomized controlled trial.
    Ludwig GD; Gemelli H; Nunes GM; Serracarbassa PD; Zanotele M
    Eur J Ophthalmol; 2021 May; 31(3):909-914. PubMed ID: 33148023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report.
    Liu X; Wang Q; Zhao J
    BMC Ophthalmol; 2020 Apr; 20(1):157. PubMed ID: 32306922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
    Vandorselaer T; Van De Velde F; Tassignon MJ
    Bull Soc Belge Ophtalmol; 2001; (280):15-9. PubMed ID: 11486460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.
    Su D; Shah CP; Hsu J
    Surv Ophthalmol; 2020; 65(5):589-591. PubMed ID: 32135173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy and Safety of YAG Laser Vitreolysis for Symptomatic Vitreous Floaters of Complete PVD or Non-PVD.
    Lin T; Li T; Zhang X; Hui Y; Moutari S; Pazo EE; Dai G; Shen L
    Ophthalmol Ther; 2022 Feb; 11(1):201-214. PubMed ID: 34778916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cataracts induced by neodymium-yttrium-aluminium-garnet laser lysis of vitreous floaters.
    Koo EH; Haddock LJ; Bhardwaj N; Fortun JA
    Br J Ophthalmol; 2017 Jun; 101(6):709-711. PubMed ID: 27574177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters.
    Luo J; An X; Kuang Y
    J Int Med Res; 2018 Nov; 46(11):4465-4471. PubMed ID: 30200800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters].
    Shaimova VA; Shaimov TB; Shaimov RB; Galin AY; Goloshchapova ZA; Ryzhkov PK; Fomin AV
    Vestn Oftalmol; 2018; 134(1):56-62. PubMed ID: 29543200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Complications after Yttrium-Aluminum-Garnet Laser Vitreolysis for Vitreous Floaters.
    Shields RA; Cheng OT; Ruby AJ; Williams GA; Wolfe JD
    Ophthalmic Surg Lasers Imaging Retina; 2021 Nov; 52(11):610-613. PubMed ID: 34766848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters: Application of Infrared Fundus Photography in Assessing the Treatment Efficacy.
    Sun X; Tian J; Wang J; Zhang J; Wang Y; Yuan G
    J Ophthalmol; 2019; 2019():8956952. PubMed ID: 30809388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.
    Katsanos A; Tsaldari N; Gorgoli K; Lalos F; Stefaniotou M; Asproudis I
    Adv Ther; 2020 Apr; 37(4):1319-1327. PubMed ID: 32086749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
    Singh IP
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):806-811. PubMed ID: 30395668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous floaters: Etiology, diagnostics, and management.
    Milston R; Madigan MC; Sebag J
    Surv Ophthalmol; 2016; 61(2):211-27. PubMed ID: 26679984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.